|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/454 | |
| A61P 25/18 |
| (11) | Number of the document | 3258935 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16710038.7 |
| Date of filing the European patent application | 2016-02-17 | |
| (97) | Date of publication of the European application | 2017-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/018316 |
| Date | 2016-02-17 |
| (87) | Number | WO 2016/134049 |
| Date | 2016-08-25 |
| (30) | Number | Date | Country code |
| 201562117173 P | 2015-02-17 | US | |
| 201562172436 P | 2015-06-08 | US |
| (72) |
POLYMEROPOULOS, Mihael H., US
WOLFGANG, Curt D., US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA |
| ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA |